Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q4 FY21 results · Jan–Mar 2021
Metropolis Healthcare reported revenue from operations of ₹291.73 crore (up 41.0% from Q4 FY20) and net profit of ₹61.32 crore (up 295.8% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 291.73 | 206.97 | +41.0% | 274.78 | +6.2% |
| Other income | 2.07 | 3.07 | −32.8% | 3.74 | −44.8% |
| Total income | 293.80 | 210.05 | +39.9% | 278.52 | +5.5% |
| Profit before tax | 81.65 | 23.39 | +249.1% | 77.77 | +5.0% |
| Net profit for the period | 61.32 | 15.49 | +295.8% | 58.64 | +4.6% |
| Attributable to shareholders of the company | 61.35 | 15.49 | +296.0% | 58.57 | +4.7% |
| EPS, basic (₹) | 12.05 | 3.09 | +290.0% | 11.50 | +4.8% |
| Net margin (%) | 21.0 | 7.5 | 21.3 |
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 238.36 | 163.16 | +46.1% | 224.43 | +6.2% |
| Other income | 42.08 | 25.72 | +63.6% | 2.37 | 18x |
| Total income | 280.44 | 188.88 | +48.5% | 226.79 | +23.7% |
| Profit before tax | 109.39 | 34.94 | +213.1% | 64.49 | +69.6% |
| Net profit for the period | 94.30 | 29.76 | +216.9% | 48.70 | +93.7% |
| EPS, basic (₹) | 18.50 | 5.93 | +212.0% | 9.56 | +93.5% |
| Net margin (%) | 39.6 | 18.2 | 21.7 |
Consolidated
- Filed with BSE
- 28 May 2021, 15:33 IST
- Board meeting
- 27 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 28 May 2021, 15:33 IST
- Board meeting
- 27 May 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE